pantoprazole has been researched along with Magnesium Deficiency in 3 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Magnesium Deficiency: A nutritional condition produced by a deficiency of magnesium in the diet, characterized by anorexia, nausea, vomiting, lethargy, and weakness. Symptoms are paresthesias, muscle cramps, irritability, decreased attention span, and mental confusion, possibly requiring months to appear. Deficiency of body magnesium can exist even when serum values are normal. In addition, magnesium deficiency may be organ-selective, since certain tissues become deficient before others. (Harrison's Principles of Internal Medicine, 12th ed, p1936)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhana, A | 1 |
| Waters, MJ | 1 |
| Fazal, MW | 1 |
| Kimber, T | 1 |
| Fernández-Fernández, FJ | 1 |
| Sesma, P | 1 |
| Caínzos-Romero, T | 1 |
| Ferreira-González, L | 1 |
| Famularo, G | 1 |
| Minisola, G | 1 |
| Bravi, MC | 1 |
| Colucci, P | 1 |
| Gasbarrone, L | 1 |
3 other studies available for pantoprazole and Magnesium Deficiency
| Article | Year |
|---|---|
Pantoprazole-induced hypomagnesaemia causing cerebellar syndrome and seizures.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Cerebellar Diseases; Female; Humans; Magnesium Defici | 2017 |
Intermittent use of pantoprazole and famotidine in severe hypomagnesaemia due to omeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Famotidine; Histamine H2 Antagonis | 2010 |
Tetany, hypomagnesemia, and proton-pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Biomarkers; Female; Humans; Hypoparathyroidism; Magnesium; | 2012 |